A Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction
Latest Information Update: 27 Nov 2024
At a glance
- Drugs Tofacitinib (Primary)
- Indications Muscle injury
- Focus Biomarker; First in man; Pharmacodynamics; Pharmacogenomic; Proof of concept
Most Recent Events
- 25 Nov 2024 Planned number of patients changed from 56 to 70.
- 25 Nov 2024 Planned End Date changed from 16 Nov 2024 to 30 Nov 2026.
- 25 Nov 2024 Planned primary completion date changed from 16 Nov 2024 to 30 Nov 2025.